The investment reflects Novo Holdings' conviction in the long-term growth of advanced wound care, increasing global demand ...
Lunit partners with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical ...
Bracco Imaging has launched the BubbleGen CD3+ T Cell Selection Kit, extending its microbubble-based, magnetic bead-free ...
At the launch of the ASEAN Care Readiness Index 2026, Lars Wismer joined Dr May-Anne Cheong of Singapore General Hospital and ...
Abbott and Sengkang General Hospital expand partnership to advance early detection of muscle loss and support healthy aging ...
China’s NMPA has cleared Fosun Pharma and Accro Bioscience to conduct an adaptive Phase II/III study of selective oral ...
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In its Mid ...
Alebund Pharmaceuticals has received FDA IND clearance for AP308, a first-in-class engineered IgA protease designed to ...
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coalition for Epidemic Preparedness Innovations (CEPI)to advance clinical ...
Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHARE Hub ...
Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial of leriglitazone in adult cerebral adrenoleukodystrophy, with top-line results expected in early 2028.
The Taiwan Excellence Pavilion officially opened on 9 Sept at Medical Fair Asia 2026, held at the Sands Expo & Convention Centre. Organised by TITA (International Trade Administra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results